Delivery Order SPE2DB25D3306-SPE2DB25FUCEN
- Not listed
- The Defense Logistics Agency awarded a $23,660 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication. The contract, which became effective on June 2, 2025, with an ultimate completion date of June 24, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen will perform work from its Conshohocken, Pennsylvania facility, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,830.00 for SKYRIZI 360 mg/2.4 ml on-body injectable medication, with a completion date of November 13, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $12,604.63 for SKYRIZI 360 mg/2.4 ml on-body injectable pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of May 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $12,467.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body 2.4ML injectable medication on October 22, 2025, with completion targeted for November 13, 2025. This non-set-aside delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the Defense Logistics Agency,...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body 2.4 mL pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was awarded on July 18, 2025. This award represents a non-set-aside, competitively awarded contract and constitutes a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed-price contract, awarded on August 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 19, 2025. No...
- The Defense Logistics Agency awarded a delivery order valued at $12,604.63 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of May 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This firm fixed-price, non-set-aside delivery order is scheduled for completion by October 20, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication in 2.4 mL quantities. The award, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, was made without a set-aside designation through competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body applicator units. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of September 11, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCENDelivery Order
The Defense Logistics Agency awarded a $11,830.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication. The award, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order derives from AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The SKYRIZI delivery order reflects routine pharmaceutical procurement operations under this established prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 7/11/25 |